Cargando…

Bone Effects of Biologic Drugs in Rheumatoid Arthritis

Biologic agents used in the treatment of rheumatoid arthritis (RA) are able to reduce both disease activity and radiographic progression of joint disease. These drugs are directed against several proinflammatory cytokines (TNFα, IL-6, and IL-1) which are involved both in the pathogenesis of chronic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Corrado, Addolorata, Neve, Anna, Maruotti, Nicola, Cantatore, Francesco Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2013
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3705836/ https://www.ncbi.nlm.nih.gov/pubmed/23864880 http://dx.doi.org/10.1155/2013/945945

Ejemplares similares

Anti-TNF-α effects on anemia in rheumatoid and psoriatic arthritis
por: Corrado, Addolorata, et al.
Publicado: (2017)

Influence of glucocorticoid treatment on trabecular bone score and bone remodeling regulators in early rheumatoid arthritis
por: Corrado, Addolorata, et al.
Publicado: (2021)

Angiogenesis Dysregulation in Psoriatic Arthritis: Molecular Mechanisms
por: Cantatore, Francesco Paolo, et al.
Publicado: (2017)

Extracellular Matrix Modulates Angiogenesis in Physiological and Pathological Conditions
por: Neve, Anna, et al.
Publicado: (2014)

Wnt Signaling and Biological Therapy in Rheumatoid Arthritis and Spondyloarthritis
por: Cici, Daniela, et al.
Publicado: (2019)

Molecular Basis of Bone Aging
por: Corrado, Addolorata, et al.
Publicado: (2020)

Osteoblast Role in Rheumatic Diseases
por: Corrado, Addolorata, et al.
Publicado: (2017)

Anti-angiogenic effects of biotechnological therapies in rheumatic diseases
por: Cantatore, Francesco Paolo, et al.
Publicado: (2017)

Osteoblast role in the pathogenesis of rheumatoid arthritis
por: Berardi, S., et al.
Publicado: (2021)

Angiogenesis Dysregulation in the Pathogenesis of Systemic Sclerosis
por: Cantatore, Francesco Paolo, et al.
Publicado: (2017)

Osteoblast role in osteoarthritis pathogenesis
por: Maruotti, Nicola, et al.
Publicado: (2017)

The role of Interleukin-1 receptor antagonist as a treatment option in calcium pyrophosphate crystal deposition disease
por: Altomare, Alberto, et al.
Publicado: (2021)

Adipokine role in physiopathology of inflammatory and degenerative musculoskeletal diseases
por: Giardullo, Liberato, et al.
Publicado: (2021)

Bone Involvement in Systemic Lupus Erythematosus
por: Rella, Valeria, et al.
Publicado: (2022)

Vitamin D Status and Psoriatic Arthritis: Association with the Risk for Sacroiliitis and Influence on the Retention Rate of Methotrexate Monotherapy and First Biological Drug Survival—A Retrospective Study
por: Rotondo, Cinzia, et al.
Publicado: (2023)

Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D Serum Levels in Systemic Sclerosis
por: Corrado, Addolorata, et al.
Publicado: (2015)

Osteoblast Dysfunction in Non-Hereditary Sclerosing Bone Diseases
por: Giardullo, Liberato, et al.
Publicado: (2021)

1,25OH-Vitamin D3 and IL-17 Inhibition Modulate Pro-Fibrotic Cytokines Production in Peripheral Blood Mononuclear Cells of Patients with Systemic Sclerosis
por: Corrado, Addolorata, et al.
Publicado: (2022)

Correction: Relationship between Body Mass Composition, Bone Mineral Density, Skin Fibrosis and 25(OH) Vitamin D Serum Levels in Systemic Sclerosis
por: Corrado, Addolorata, et al.
Publicado: (2015)

Macrophages and angiogenesis in rheumatic diseases
por: Maruotti, Nicola, et al.
Publicado: (2013)

Anti-cyclic-citrullinated-protein-antibodies in psoriatic arthritis patients: how autoimmune dysregulation could affect clinical characteristics, retention rate of methotrexate monotherapy and first line biotechnological drug survival. A single center retrospective study.
por: Rotondo, Cinzia, et al.
Publicado: (2021)

Low-Dose Aspirin as Primary Prophylaxis for Cardiovascular Events in Rheumatoid Arthritis: An Italian Multicentre Retrospective Study
por: Iacono, Daniela, et al.
Publicado: (2019)

Off-label use of anti-IL-1 drugs in rheumatic diseases
por: Stefania, Silvia, et al.
Publicado: (2021)

Postmenopausal women presenting with spinal fractures and the importance of primary care: A case-series
por: Colia, Ripalta, et al.
Publicado: (2020)

Using the Immunophenotype to Predict Response to Biologic Drugs in Rheumatoid Arthritis
por: Mulhearn, Ben, et al.
Publicado: (2019)

Positive Effects of Biologics on Osteoporosis in Rheumatoid Arthritis
por: Kim, Yunkyung, et al.
Publicado: (2023)

Effects of Different Vitamin D Supplementation Schemes in Post-Menopausal Women: A Monocentric Open-Label Randomized Study
por: Corrado, Addolorata, et al.
Publicado: (2021)

JAK/STAT pathway and molecular mechanism in bone remodeling
por: Sanpaolo, Eliana Rita, et al.
Publicado: (2020)

Biologic and oral disease-modifying antirheumatic drug monotherapy in rheumatoid arthritis
por: Emery, Paul, et al.
Publicado: (2013)

Preliminary Data on Post Market Safety Profiles of COVID 19 Vaccines in Rheumatic Diseases: Assessments on Various Vaccines in Use, Different Rheumatic Disease Subtypes, and Immunosuppressive Therapies: A Two-Centers Study
por: Rotondo, Cinzia, et al.
Publicado: (2021)

The Emerging Role of Curcumin in the Modulation of TLR-4 Signaling Pathway: Focus on Neuroprotective and Anti-Rheumatic Properties
por: Panaro, Maria Antonietta, et al.
Publicado: (2020)

Effects of Biological Therapies on Molecular Features of Rheumatoid Arthritis
por: Lopez-Pedrera, Chary, et al.
Publicado: (2020)

Biologic monotherapy in the treatment of rheumatoid arthritis
por: Detert, Jacqueline, et al.
Publicado: (2015)

Effect of biologics and targeted synthetic disease-modifying anti-rheumatic drugs on fatigue in rheumatoid arthritis
por: Choy, Ernest H
Publicado: (2019)

Genetics of rheumatoid arthritis contributes to biology and drug discovery
por: Okada, Yukinori, et al.
Publicado: (2013)

Bone Involvement in Rheumatoid Arthritis and Spondyloartritis: An Updated Review
por: Orsini, Francesco, et al.
Publicado: (2023)

The potential value of blood monitoring of biologic drugs used in the treatment of rheumatoid arthritis
por: Perry, Martin, et al.
Publicado: (2020)

Bone Remodelling Markers in Rheumatoid Arthritis
por: Fardellone, Patrice, et al.
Publicado: (2014)

Polymorphisms Involved in Response to Biological Agents Used in Rheumatoid Arthritis
por: Pallio, Giovanni, et al.
Publicado: (2020)

Treatment with Biologicals in Rheumatoid Arthritis: An Overview
por: Rein, Philipp, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_u16fhlbgcr67d4cgsem0utgr47